share_log

Baird Maintains Outperform on Twist Bioscience, Raises Price Target to $48

Benzinga ·  Nov 19 04:53  · Ratings

Baird analyst Catherine Ramsey maintains Twist Bioscience (NASDAQ:TWST) with a Outperform and raises the price target from $46 to $48.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment